Skip to Main Navigation
Skip to Page Content
COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/14846

Indium phosphide: Target Organs and Levels of Evidence for TR-499

Toxicology and Carcinogenesis Studies of Indium Phosphide (CASRN 22398-80-7) in F344/N Rats and B6C3F1 Mice (Inhalation Studies)

Chemical (Study Title)
CASRN		Peer Review DateRoute/Exposure LevelsStudy Laboratory
Indium phosphide
22398-80-7		05/18/2000Inhalation
R&M: 0, 0.03, 0.1, OR 0.3 MG/M3		Battelle Northwest Laboratory

Levels of Evidence

Male Rats: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Lung: ALVEOLAR/BRONCHIOLAR ADEMONA 6/50 13/50 27/50 30/50; ALVEOLAR/BRONCHIOLAR CARCINOMA 1/50 10/50 8/50 16/50; COMBINED 7/50 22/50 30/50 35/50; SQUAMOUS CELL CARCINOMA 0/50 0/50 0/50 4/50
  • Adrenal Gland Medulla: BENIGN PHEOCHROMOCYTOMA 10/50 22/50 16/49 23/50 BENIGN OR MALIGNANT PHEOCHROMOCYTOMA 10/50 26/50 18/49 24/50
May Have Been Related
  • Hematopoietic System: MONONUCLEAR CELL LEUKEMIA 16/50 23/50 29/50 25/50
  • Skin: FIBROMA 1/50 4/50 7/50 3/50; FIBROMA OR FIBROSARCOMA 2/50 4/50 8/50 4/50
Non-Neoplastic Lesions
  • LUNG: ATYPICAL HYPERPLASIA; CHRONIC ACTIVE INFLAMMATION; ALVEOLAR EPITHELIUM METAPLASIA; ALVEOLUS PROTEINOSIS; INTERSTITIUM FIBROSIS; ALVEOLAR EPITHELIUM HYPERPLASIA
Female Rats: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Lung: ALVEOLAR/BRONCHIOLAR ADEMONA 0/50 7/50 5/50 19/50; ALVEOLAR/BRONCHIOLAR CARCINOMA 1/50 3/50 1/50 11/50; COMBINED 1/50 10/50 6/50 26/50
  • Adrenal Gland Medulla: BENIGN PHEOCHROMOCYTOMA 2/50 6/48 2/50 9/49
May Have Been Related
  • Hematopoietic System: MONONUCLEAR CELL LEUKEMIA 14/50 21/50 14/50 24/50
  • Mammary Gland: CARCINOMA 0/50 8/50 3/50 2/50
Non-Neoplastic Lesions
  • LUNG: ATYPICAL HYPERPLASIA; CHRONIC ACTIVE INFLAMMATION; ALVEOLAR EPITHELIUM METAPLASIA; ALVEOLUS PROTEINOSIS; INTERSTITIUM FIBROSIS; ALVEOLAR EPITHELIUM HYPERPLASIA; SQUAMOUS CYST
  • ADRENAL GLAND: (MEDULLA) HYPERPLASIA
Male Mice: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Lung: ALVEOLAR/BRONCHIOLAR CARCINOMA 6/50 15/50 22/50 13/50
  • Liver: ADENOMA 17/50 24/50 23/50 32/50; CARCINOMA 11/50 22/50 23/50 16/50; COMBINED 26/50 40/50 37/50 39/50
May Have Been Related
  • Intestines: CARCINOMA 0/50 1/50 5/50 3/50; ADEMONA OR CARCINOMA 1/50 2/50 6/50 3/50
Non-Neoplastic Lesions
  • LUNG: CHRONIC ACTIVE INFLAMMATION; ALVEOLUS PROTEINOSIS; SEROSA FIBROSIS; PLEURA MESOTHELIUM HYPERPLASIA
  • LIVER: EOSINOPHLILIC FOCUS
  • HEART: (ARTERY) INFLAMMATION
Female Mice: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Lung: ALVEOLAR/BRONCHIOLAR ADEMONA 3/50 6/50 10/50 7/50; ALVEOLAR/BRONCHIOLAR CARCINOMA 1/50 6/50 5/50 7/50; COMBINED 4/50 11/50 15/50 14/50
  • Liver: ADENOMA 12/50 14/50 18/50 14/50; CARCINOMA 6/50 17/50 8/50 10/50; COMBINED 18/50 28/50 24/50 23/50
Non-Neoplastic Lesions
  • LUNG: CHRONIC ACTIVE INFLAMMATION; ALVEOLUS PROTEINOSIS; SEROSA FIBROSIS; PLEURA MESOTHELIUM HYPERPLASIA
  • LIVER: EOSINOPHILIC FOCUS
  • HEART: (ARTERY) INFLAMMATION